Kang, M.; Shin, Y.; Kim, Y.; Ha, S.; Sung, W.
Modeling the Synergistic Impact of Yttrium 90 Radioembolization and Immune Checkpoint Inhibitors on Hepatocellular Carcinoma. Bioengineering 2024, 11, 106.
https://doi.org/10.3390/bioengineering11020106
AMA Style
Kang M, Shin Y, Kim Y, Ha S, Sung W.
Modeling the Synergistic Impact of Yttrium 90 Radioembolization and Immune Checkpoint Inhibitors on Hepatocellular Carcinoma. Bioengineering. 2024; 11(2):106.
https://doi.org/10.3390/bioengineering11020106
Chicago/Turabian Style
Kang, Minah, Yerim Shin, Yeseul Kim, Sangseok Ha, and Wonmo Sung.
2024. "Modeling the Synergistic Impact of Yttrium 90 Radioembolization and Immune Checkpoint Inhibitors on Hepatocellular Carcinoma" Bioengineering 11, no. 2: 106.
https://doi.org/10.3390/bioengineering11020106
APA Style
Kang, M., Shin, Y., Kim, Y., Ha, S., & Sung, W.
(2024). Modeling the Synergistic Impact of Yttrium 90 Radioembolization and Immune Checkpoint Inhibitors on Hepatocellular Carcinoma. Bioengineering, 11(2), 106.
https://doi.org/10.3390/bioengineering11020106